Isis Pharmaceuticals (ISIS)

Senior Vice President, Antisense Research

Dr. Bennett was promoted to Senior Vice President, Research in January 2006. From June 1995 to January 2006, Dr. Bennett served as our Vice President, Research. From March 1993 to June 1995, he was Director, Molecular Pharmacology, and from May 1992 to March 1993, he was an Associate Director in our Molecular and Cellular Biology department. Prior to joining Isis in 1989, Dr. Bennett was employed by SmithKline and French Laboratories in various research positions. He serves on the Scientific Advisory Board of Keystone Symposia, a non-profit organization dedicated to connecting the scientific community for the benefit of society, and is an external member of the Scientific Advisory Board of Experimental Therapeutics Center in Singapore.

RICHARD S. GEARY, Ph.D.

Senior Vice President, Antisense Research

Dr. Bennett was promoted to Senior Vice President, Research in January 2006. From June 1995 to January 2006, Dr. Bennett served as our Vice President, Research. From March 1993 to June 1995, he was Director, Molecular Pharmacology, and from May 1992 to March 1993, he was an Associate Director in our Molecular and Cellular Biology department. Prior to joining Isis in 1989, Dr. Bennett was employed by SmithKline and French Laboratories in various research positions. He serves on the Scientific Advisory Board of Keystone Symposia, a non-profit organization dedicated to connecting the scientific community for the benefit of society, and is an external member of the Scientific Advisory Board of Experimental Therapeutics Center in Singapore.

RICHARD S. GEARY, Ph.D.

Senior Vice President, Antisense Research

Dr. Bennett was promoted
to Senior Vice President, Research in January 2006. From June 1995 to
January 2006, Dr. Bennett served as our Vice President, Research.
From March 1993 to June 1995, he was Director, Molecular
Pharmacology, and from May 1992 to March 1993, he was an Associate
Director in our Molecular and Cellular Biology department. Prior to joining Isis in 1989, Dr. Bennett
was employed by SmithKline and French Laboratories in various research
positions. He serves on the Scientific Advisory Board of Keystone Symposia, a
non-profit organization dedicated to connecting the scientific community for
the benefit of society, and is an external member of the Scientific Advisory
Board of Experimental Therapeutics Center in Singapore.

RICHARD S. GEARY, Ph.D.

Senior Vice President, Antisense Research

Dr. Bennett was promoted
to Senior Vice President, Research in January 2006. From June 1995 to
January 2006, Dr. Bennett served as our Vice President, Research.
From March 1993 to June 1995, he was Director, Molecular
Pharmacology, and from May 1992 to March 1993, he was an Associate
Director in our Molecular and Cellular Biology department. Prior to joining Isis in 1989, Dr. Bennett
was employed by SmithKline and French Laboratories in various research
positions. He serves on the Scientific Advisory Board of Keystone Symposia, a
non-profit organization dedicated to connecting the scientific community for
the benefit of society, and is an external member of the Scientific Advisory
Board of Experimental Therapeutics Center in Singapore.

RICHARD S. GEARY, Ph.D.

Senior Vice President, Antisense Research

Dr. Bennett was promoted
to Senior Vice President, Research in January 2006. From June 1995 to
January 2006, Dr. Bennett served as our Vice President, Research.
From March 1993 to June 1995, he was Director, Molecular
Pharmacology, and from May 1992 to March 1993, he was an Associate
Director in our Molecular and Cellular Biology department. Prior to joining Isis in 1989, Dr. Bennett
was employed by SmithKline and French Laboratories in various research
positions. He serves on the Scientific Advisory Board of Keystone Symposia, a
non-profit organization dedicated to connecting the scientific community for
the benefit of society, and is an external member of the Scientific Advisory
Board of Experimental Therapeutics Center in Singapore.

RICHARD S. GEARY, Ph.D.

Senior Vice President, Antisense Research

        Dr. Bennett was promoted to Senior Vice President, Research in January 2006. From June 1995 to January 2006, Dr. Bennett served as our Vice President, Research. From March 1993 to June 1995, he was Director, Molecular Pharmacology, and from May 1992 to March 1993, he was an Associate Director in our Molecular and Cellular Biology department. Prior to joining Isis in 1989, Dr. Bennett was employed by SmithKline and French Laboratories in various research positions. He serves as a Director of Antisense Therapeutics Ltd., a biopharmaceutical company.

DAVID J. ECKER, Ph.D.

Senior Vice President, Antisense Research

        Dr. Bennett was promoted to Senior Vice President, Research in January 2006. From June 1995 to January 2006, Dr. Bennett served as our Vice
President, Research. From March 1993 to June 1995, he was Director, Molecular Pharmacology, and from May 1992 to March 1993, he was an Associate Director in our Molecular and Cellular Biology
department. Prior to joining Isis in 1989, Dr. Bennett was employed by SmithKline and French Laboratories in various research positions. He serves as a Director of Antisense
Therapeutics Ltd., a biopharmaceutical company.

DAVID
J. ECKER, Ph.D.